<code id='D9D6ECF617'></code><style id='D9D6ECF617'></style>
    • <acronym id='D9D6ECF617'></acronym>
      <center id='D9D6ECF617'><center id='D9D6ECF617'><tfoot id='D9D6ECF617'></tfoot></center><abbr id='D9D6ECF617'><dir id='D9D6ECF617'><tfoot id='D9D6ECF617'></tfoot><noframes id='D9D6ECF617'>

    • <optgroup id='D9D6ECF617'><strike id='D9D6ECF617'><sup id='D9D6ECF617'></sup></strike><code id='D9D6ECF617'></code></optgroup>
        1. <b id='D9D6ECF617'><label id='D9D6ECF617'><select id='D9D6ECF617'><dt id='D9D6ECF617'><span id='D9D6ECF617'></span></dt></select></label></b><u id='D9D6ECF617'></u>
          <i id='D9D6ECF617'><strike id='D9D6ECF617'><tt id='D9D6ECF617'><pre id='D9D6ECF617'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:4
          HHS 2020
          PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

          WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

          The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

          advertisement

          PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Treeline, Josh Bilenker's next biotech, is cloaked in mystery
          Treeline, Josh Bilenker's next biotech, is cloaked in mystery

          APPhoto/TedS.WarrenJoshBilenker’slastcompany,LoxoOncology,waspurchasedbyEliLillyfor$8billion.Nosurpr

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          OTC birth control: A brief history of over the counter pill design

          Illustration:AlexHogan/STAT;Photo:CourtesyPerrigoIt’snoteverydaythatamarketingteamistaskedwithdesign